BETA vs EXAS · rev $8.9M vs rev $2.76B
Beta Technologies, Inc. (BETA) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Beta Technologies, Inc. (BETA) is a aerospace & defense company listed on NYSE.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported BETA revenue for 2025-09-30 was $8.9M. Net income was -$437.2M. Revenue was up 190.9% from 2024-09-30 to 2025-09-30. BETA currently screens at market cap $3.72B.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
BETA currently screens at market cap $3.72B. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the BETA and EXAS stock pages for the full models.
Not investment advice.